A Randomized, Double-blind, Controlled Trial to Evaluate the Safety and Immunogenicity of Killed Bivalent (o1 and o139) Whole-cell Based Oral Cholera Vaccine (Shanchol) in Healthy Individuals in Ethiopia.

Trial Profile

A Randomized, Double-blind, Controlled Trial to Evaluate the Safety and Immunogenicity of Killed Bivalent (o1 and o139) Whole-cell Based Oral Cholera Vaccine (Shanchol) in Healthy Individuals in Ethiopia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs Cholera vaccine inactivated (Primary)
  • Indications Cholera
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 24 Sep 2013 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov record.
    • 21 Aug 2012 Planned initiation date changed from 1 Mar 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov record.
    • 21 Aug 2012 Planned End Date changed from 1 Jul 2012 to 1 Apr 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top